Weazel perhaps we should list on the nasdaq as 007 catalyst has stated a number of times that we are a US based company. Sight are many times our present valuation despite that they have significant debt and are not profitable. We have no debt and are nearly profitable and we have the 2RT elephant in the room. I know listing is a difficult and expensive process but if the 2RT business comes to fruition our pricing on nasdaq could be many times what it would be on the asx so I would list there .
Nova Eye Medical (EYE) Discussion, page-2087
-
- There are more pages in this discussion • 1,055 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.005(2.33%) |
Mkt cap ! $50.34M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 21.5¢ | $77.61K | 360.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 203513 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 31852 | 2 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| EYE (ASX) Chart |